Raymond James Cuts AngioDynamics (ANGO) to Market Perform
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.85 +1.21%
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Raymond James downgraded AngioDynamics (NASDAQ: ANGO) from Outperform to Market Perform.
The lowered investment rating follow news the company's President and CEO resigned. AngioDynamics also provided preliminary Q4 results that came in below the Street.
For more ratings news on AngioDynamics click here and for the rating history of AngioDynamics click here.
The lowered investment rating follow news the company's President and CEO resigned. AngioDynamics also provided preliminary Q4 results that came in below the Street.
For more ratings news on AngioDynamics click here and for the rating history of AngioDynamics click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
